Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Marker Therapeutics Inc (MRKR)  
$4.09 0.04 (0.97%) as of 4:30 Mon 5/13


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 8,798,000
Market Cap: 35.98(M)
Last Volume: 9,790 Avg Vol: 9,763
52 Week Range: $1.19 - $8.78
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Marker Therapeutics is a clinical-stage immuno-oncology company focusing on the development of T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Co. is developing three product candidates as part of its multi tumor associated antigen-specific T cell program for: autologous treatment of lymphoma, and selected solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia (AML); and off-the-shelf products in various indications. Co.'s clinical development programs are: MT-401 for the treatment of post-transplant AML; MT-401-OTS for the treatment of AML; and MT-601 for the treatment of lymphoma.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 67
  Page 3 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Reddish Mark Director   –       •      –    2017-08-29 4 A $0.00 $0 D/D 13,115 32,004     -
   Silverman Joshua Director   –       •      –    2017-08-29 4 A $0.00 $0 D/D 13,115 13,115     -
   Wasserman Frederick Gerald Director   –       •      –    2017-08-29 4 A $0.00 $0 D/D 13,115 13,115     -
   Laskow-Pooley David Director   –       •      –    2017-08-29 4 A $0.00 $0 D/D 13,115 13,115     -
   Grisewood Sherry Director   –       •      –    2017-08-29 4 A $0.00 $0 D/D 13,115 15,476     -
   Bonfiglio John N President and COO   •       •      –    2016-12-12 4 GA $0.00 $0 I/I 10,417 10,417     -
   Bonfiglio John N President and COO   •       •      –    2016-12-12 4 GD $0.00 $0 D/D 10,417 20,834     -
   Bonfiglio John N President and COO   •       •      –    2016-12-12 4 OE $1.74 $18,126 D/D 10,417 31,251     -
   Dart Kenneth Bryan 10% Owner   –       –       •   2016-08-10 4 A $0.00 $0 D/D 3,000,000 28,000,000     -
   Dart Kenneth Bryan 10% Owner   –       –       •   2016-08-10 4 OE $0.50 $2,500,000 D/D 5,000,000 25,000,000     -
   Bonfiglio John N See Remarks   •       •      –    2016-07-15 4 A $0.00 $0 D/D 250,000 250,000     -
   Wilson Glynn Director   –       •      –    2015-11-12 4 A $0.61 $52,503 D/D 86,782 873,675     -
   Wilson Glynn Director   –       •      –    2015-11-12 4 A $0.61 $190,575 D/D 315,000 960,457     -
   Dart Kenneth Bryan 10% Owner   –       –       •   2015-09-09 4 OE $0.20 $2,000,000 D/D 10,000,000 20,000,000     -
   Dart Kenneth Bryan 10% Owner   –       –       •   2015-06-16 4 OE $0.50 $2,500,000 D/D 5,000,000 10,000,000     -
   Dart Kenneth Bryan 10% Owner   –       –       •   2015-03-09 3 IO $0.00 $0 D/D 0 5,000,000     -
   Wilson Glynn Director   –       •      –    2014-12-02 4 A $1.00 $120,000 D/D 120,000 645,457     -

  67 Records found
  1  2  3    
  Page 3 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed